Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences

Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences

Type 2 leprosy reaction (T2LR), or Erythema Nodosum Leprosum (ENL), often poses a therapeutic challenge to clinicians and commonly requires long courses of steroids for control. While immunosuppressants are known to achieve control and lower steroid dependence in T2LR, the prospect of managing a sev...

Full description

Bibliographic Details
Main Authors: Snigdha Saxena, Ananta Khurana, Savitha B, Kabir Sardana, Aastha Agarwal, Aishwarya Muddebihal, Alok Raina, Purnima Paliwal
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220325479

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220325479

Similar Items